← back to search

Kristin Huang

Tufts University · US
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Glioma Diagnosis and Treatment, Epigenetics and DNA Methylation, Drug-Induced Adverse Reactions, and Pain Management and Opioid Use.
h-index
18
citations
6,054
works
35
NIH funding
primary concept
email

Recent publications

Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course
Acta Neuropathologica 2019cited by 131position: middledoi
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
Acta Neuropathologica Communications 2019cited by 62position: middledoi
DNA methylation-based classification of central nervous system tumours
Nature 2018cited by 3,091position: middledoi
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
Acta Neuropathologica 2018cited by 584position: middledoi
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas
Acta Neuropathologica 2018cited by 466position: middledoi
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations
Acta Neuropathologica 2018cited by 279position: middledoi
FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma
Acta Neuropathologica 2018cited by 82position: middledoi
Diagnostic accuracy of DW MR imaging in the differentiation of chordomas and chondrosarcomas of the skull base: A 3.0-T MRI study of 105 cases
European Journal of Radiology 2018cited by 32position: middledoi
Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas
European Journal of Nuclear Medicine and Molecular Imaging 2018cited by 26position: middledoi
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
The Lancet Oncology 2017cited by 845position: middledoi
Evidence of H3 K27M mutations in posterior fossa ependymomas
Acta Neuropathologica 2016cited by 94position: middledoi
Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas
Acta Neuropathologica 2016cited by 17position: middledoi
HG-68COMBINED ALTERATIONS IN MAPK PATHWAY GENES, CDKN2A/B AND ATRX CHARACTERIZE ANAPLASTIC PILOCYTIC ASTROCYTOMA
Neuro-Oncology 2016cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andreas von Deimling · Stiftung Schleswig-Holsteinische Landesmuseen4 papers (2016–2018)David Jones · Mayo Clinic in Florida2 papers (2016–2016)Daniel Schrimpf · German Cancer Research Center2 papers (2016–2018)David Capper · German Cancer Research Center2 papers (2016–2016)Stefan M. Pfister · Université du Québec2 papers (2016–2016)Felix Sahm · Heidelberg (Poland)2 papers (2016–2016)Christian Koelsche · Ludwig-Maximilians-Universität München1 papers (2016–2016)Eva Meyerhof · University Hospital Heidelberg1 papers (2018–2018)Björn-Ole Juhnke · University Hospital Heidelberg1 papers (2016–2016)Annika K. Wefers · University Hospital Regensburg1 papers (2016–2016)Sebastian Brandner · University College London Hospitals NHS Foundation Trust1 papers (2016–2016)Stefan Rutkowski · Universität Hamburg1 papers (2016–2016)Damian Stichel · German Cancer Research Center1 papers (2016–2016)Antonia Dimitrakopoulou‐Strauss · German Cancer Research Center1 papers (2018–2018)Uwe Haberkorn · Heidelberg University1 papers (2018–2018)Andreas Unterberg · Heidelberg University1 papers (2016–2016)Dominik Sturm · German Cancer Research Center1 papers (2016–2016) · 1 papers (2016–2016)Michel Mittelbronn · Centre Hospitalier de Luxembourg1 papers (2016–2016)Joachim Alfer · Friedrich-Alexander-Universität Erlangen-Nürnberg1 papers (2016–2016)